{
    "2018-02-16": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Top Research Reports for Novo Nordisk, TJX Companies & Cigna",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "TJX Companies",
                        "Cigna"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Why 2018 Could Be An 'Explosive' Year For Biotech Mergers",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Mergers",
                        "Explosive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Stocks To Watch: Bristol-Myers Squibb Sees RS Rating Jump To 83",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "RS Rating",
                        "Jump"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}